Open AccessThe efficacy and safety of quantitative flow ratio-guided complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A pilot randomized controlled trial
Author(s) -
Jing Zhang,
Mingyan Yao,
Jia Xinwei,
Hailan Feng,
Jingjing Fu,
Wei Tang,
Hongliang Cong
Publication year - 2023
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0111
Subject(s) - medicine , cardiology , myocardial infarction , hazard ratio , revascularization , unstable angina , stroke (engine) , clinical endpoint , heart failure , population , coronary artery disease , angina , confidence interval , randomized controlled trial , mechanical engineering , environmental health , engineering
In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), the treatment strategy for non-infarct-related artery (non-IRA) remains controversial. Quantitative flow ratio (QFR) is a new angiography-based physiological assessment index. However, there is little evidence on the practical clinical application of QFR.